共有 50 笔近期内部人交易记录记录，涉及 Pacira BioSciences, Inc. (PCRX), 包括 23 笔买入 和 26 笔卖出. 内部人买入总额为 $5.63M 内部人卖出总额为 $4.43M.
近期活跃的重要内部人包括 Froimson Mark, Slonin Jonathan, Williams Kristen. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — PCRX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-17 |
Froimson Mark |
Director |
知情卖出 |
500 |
$21.81 |
$10.91K |
20,136 |
| 2026-03-17 |
Slonin Jonathan |
Chief Medical Officer |
知情卖出 |
3,261 |
$22.82 |
$74.42K |
223,640 |
| 2026-02-11 |
Williams Kristen |
Chief Administrative Officer |
限制性股票授予 (RSU) |
54,546 |
- |
- |
185,849 |
| 2026-02-11 |
Riker Lauren |
Senior Vice President, Finance |
限制性股票授予 (RSU) |
19,273 |
- |
- |
71,586 |
| 2026-02-11 |
Cross Shawn |
Chief Financial Officer |
限制性股票授予 (RSU) |
49,091 |
- |
- |
105,341 |
| 2026-02-11 |
Lee Frank D. |
Chief Executive Officer |
限制性股票授予 (RSU) |
261,818 |
- |
- |
660,831 |
| 2026-02-11 |
Slonin Jonathan |
Chief Medical Officer |
限制性股票授予 (RSU) |
54,546 |
- |
- |
226,901 |
| 2026-02-11 |
Teehan Brendan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
51,714 |
- |
- |
100,934 |
| 2026-02-02 |
Williams Kristen |
Chief Administrative Officer |
知情卖出 |
13,137 |
$20.53 |
$269.7K |
131,303 |
| 2026-02-02 |
Riker Lauren |
Senior Vice President, Finance |
知情卖出 |
4,000 |
$20.81 |
$83.24K |
52,313 |
| 2026-01-30 |
Williams Kristen |
Chief Administrative Officer |
RSU 预扣税 |
17,134 |
$20.54 |
$351.93K |
144,440 |
| 2026-01-30 |
Riker Lauren |
Senior Vice President, Finance |
RSU 预扣税 |
2,751 |
$20.54 |
$56.51K |
56,313 |
| 2026-01-30 |
Lee Frank D. |
Chief Executive Officer |
RSU 预扣税 |
41,488 |
$20.54 |
$852.16K |
399,013 |
| 2026-01-30 |
Slonin Jonathan |
Chief Medical Officer |
RSU 预扣税 |
6,168 |
$20.54 |
$126.69K |
172,355 |
| 2026-01-30 |
Teehan Brendan |
Chief Commercial Officer |
RSU 预扣税 |
5,182 |
$20.54 |
$106.44K |
49,220 |
| 2026-01-27 |
Hirawat Samit |
Director |
未知 |
- |
- |
- |
- |
| 2026-01-27 |
Hirawat Samit |
Director |
限制性股票授予 (RSU) |
39,291 |
$19.85 |
$779.93K |
39,291 |
| 2026-01-05 |
Riker Lauren |
Senior Vice President, Finance |
知情卖出 |
1,416 |
$24.24 |
$34.32K |
59,064 |
| 2026-01-02 |
Riker Lauren |
Senior Vice President, Finance |
RSU 预扣税 |
159 |
$24.46 |
$3.89K |
60,480 |
| 2026-01-02 |
Lee Frank D. |
Chief Executive Officer |
RSU 预扣税 |
9,272 |
$24.46 |
$226.79K |
440,501 |
| 2026-01-02 |
Slonin Jonathan |
Chief Medical Officer |
RSU 预扣税 |
381 |
$24.46 |
$9.32K |
178,523 |
| 2025-12-31 |
Teehan Brendan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
402 |
$10.76 |
$4.33K |
54,402 |
| 2025-12-10 |
Cross Shawn |
Chief Financial Officer |
知情卖出 |
9,104 |
$25.14 |
$228.87K |
56,250 |
| 2025-12-09 |
Cross Shawn |
Chief Financial Officer |
知情卖出 |
15,896 |
$25.03 |
$397.88K |
56,250 |
| 2025-11-17 |
Slonin Jonathan |
Chief Medical Officer |
知情卖出 |
3,960 |
$24.09 |
$95.4K |
178,367 |
| 2025-11-10 |
Cross Shawn |
Chief Financial Officer |
知情卖出 |
12,060 |
$22.09 |
$266.41K |
56,250 |
| 2025-10-31 |
Cross Shawn |
Chief Financial Officer |
RSU 预扣税 |
6,690 |
$21.38 |
$143.03K |
68,310 |
| 2025-09-04 |
Ceesay Abraham |
Director |
知情卖出 |
2,354 |
$27.19 |
$64.01K |
9,039 |
| 2025-08-07 |
Bigal Marcelo |
Director |
知情卖出 |
4,912 |
$23.67 |
$116.27K |
11,393 |
| 2025-08-01 |
Slonin Jonathan |
Chief Medical Officer |
RSU 预扣税 |
315 |
$22.07 |
$6.95K |
182,327 |
| 2025-06-11 |
Kronenfeld Mark A. |
Director |
限制性股票授予 (RSU) |
6,163 |
- |
- |
31,065 |
| 2025-06-11 |
Brege Laura |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Kronenfeld Mark A. |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Yang Michael J. |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Froimson Mark |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Ceesay Abraham |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Christie Christopher |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Young Alethia |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-11 |
Bigal Marcelo |
Director |
限制性股票授予 (RSU) |
11,279 |
$24.34 |
$274.53K |
11,279 |
| 2025-06-04 |
Williams Kristen |
Chief Administrative Officer |
知情卖出 |
14,376 |
$26.24 |
$377.23K |
161,574 |
| 2025-06-04 |
Riker Lauren |
Senior Vice President, Finance |
知情卖出 |
5,578 |
$26.21 |
$146.2K |
59,564 |
| 2025-06-03 |
Williams Kristen |
Chief Administrative Officer |
RSU 预扣税 |
6,162 |
$26.40 |
$162.68K |
175,950 |
| 2025-06-03 |
Riker Lauren |
Senior Vice President, Finance |
RSU 预扣税 |
3,374 |
$26.40 |
$89.07K |
65,142 |
| 2025-06-03 |
Slonin Jonathan |
Chief Medical Officer |
RSU 预扣税 |
5,084 |
$26.40 |
$134.22K |
181,960 |
| 2025-02-04 |
Teehan Brendan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
99,500 |
$26.59 |
$2.65M |
99,500 |
| 2025-02-01 |
Williams Kristen |
Chief Administrative Officer |
限制性股票授予 (RSU) |
79,200 |
- |
- |
182,112 |
| 2025-02-01 |
Riker Lauren |
Senior Vice President, Finance |
限制性股票授予 (RSU) |
30,600 |
- |
- |
68,516 |
| 2025-02-01 |
Lee Frank D. |
Chief Executive Officer |
限制性股票授予 (RSU) |
350,000 |
- |
- |
448,409 |
| 2025-02-01 |
Slonin Jonathan |
Chief Medical Officer |
限制性股票授予 (RSU) |
93,600 |
- |
- |
187,044 |
| 2025-02-01 |
Teehan Brendan |
Chief Commercial Officer |
限制性股票授予 (RSU) |
54,000 |
- |
- |
54,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
